Eosinophilic Esophagitis Drug Market 2027 By Drug Type, Distribution Channel and Geography | The Insight Partners

Eosinophilic Esophagitis Drug Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Type (Proton Pump Inhibitor (PPI), Topical Steroid) ; Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00008611 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Eosinophilic esophagitis (EoE) is a chronic, allergic inflammatory disease of the esophagus (the tube connecting the mouth to the stomach). It occurs when a type of white blood cell, the eosinophil, accumulates in the esophagus.

MARKET DYNAMICS

Eosinophilic esophagitis is a rare disease, but increasing in prevalence with an estimated 1 out of 2,000 people affected is going to drive the market growth in the study period. Moreover, growing number of drug approvals are projected to further spur the market growth. For, instance on October, 2019 Takeda Pharmaceuticals U.S.A., Inc., completed its First-Ever U.S. Pivotal Phase 3 Clinical Study in Eosinophilic Esophagitis (EoE).

MARKET SCOPE

The "Global Eosinophilic Esophagitis Drug Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Eosinophilic Esophagitis Drug Market with detailed market segmentation by drug type, distribution channel, and geography. The Global Eosinophilic Esophagitis Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Eosinophilic Esophagitis Drug Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Eosinophilic Esophagitis Drug Market is segmented on the basis of drug type and distribution channel. On the basis of drug type, market can be classified as proton pump inhibitor (PPI), topical steroid. The topical steroid is further segmented into fluticasone and budesonide. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Eosinophilic Esophagitis Drug Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Eosinophilic Esophagitis Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Eosinophilic Esophagitis Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Eosinophilic Esophagitis Drug Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Eosinophilic Esophagitis Drug Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Eosinophilic Esophagitis Drug Market are anticipated to lucrative growth opportunities in the future with the rising demand for Eosinophilic Esophagitis Drug Market in the global market. Below mentioned is the list of few companies engaged in the Eosinophilic Esophagitis Drug Market.

The report also includes the profiles of key Eosinophilic Esophagitis Drug Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Boston Scientific Corporation
- AstraZeneca
- GSK
- Adare Pharmaceuticals
- DBV Technologies
- Dr. Falk Pharma
- Quorum Innovations
- Takeda Pharmaceuticals
- Calypso Biotech
- Celgene
- Regeneron

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Eosinophilic Esophagitis Drug Market - By Drug Type
1.3.2 Eosinophilic Esophagitis Drug Market - By Distribution Channel
1.3.3 Eosinophilic Esophagitis Drug Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. EOSINOPHILIC ESOPHAGITIS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. EOSINOPHILIC ESOPHAGITIS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. EOSINOPHILIC ESOPHAGITIS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. EOSINOPHILIC ESOPHAGITIS DRUG - GLOBAL MARKET OVERVIEW
6.2. EOSINOPHILIC ESOPHAGITIS DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. EOSINOPHILIC ESOPHAGITIS DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROTON PUMP INHIBITOR (PPI)
7.3.1. Overview
7.3.2. Proton Pump Inhibitor (PPI) Market Forecast and Analysis
7.4. TOPICAL STEROID
7.4.1. Overview
7.4.2. Topical Steroid Market Forecast and Analysis
7.4.3. Fluticasone Market
7.4.3.1. Overview
7.4.3.2. Fluticasone Market Forecast and Analysis
7.4.4. Budesonide Market
7.4.4.1. Overview
7.4.4.2. Budesonide Market Forecast and Analysis
8. EOSINOPHILIC ESOPHAGITIS DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. EOSINOPHILIC ESOPHAGITIS DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Eosinophilic Esophagitis Drug Market Overview
9.1.2 North America Eosinophilic Esophagitis Drug Market Forecasts and Analysis
9.1.3 North America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Drug Type
9.1.4 North America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Eosinophilic Esophagitis Drug Market
9.1.5.1.1 United States Eosinophilic Esophagitis Drug Market by Drug Type
9.1.5.1.2 United States Eosinophilic Esophagitis Drug Market by Distribution Channel
9.1.5.2 Canada Eosinophilic Esophagitis Drug Market
9.1.5.2.1 Canada Eosinophilic Esophagitis Drug Market by Drug Type
9.1.5.2.2 Canada Eosinophilic Esophagitis Drug Market by Distribution Channel
9.1.5.3 Mexico Eosinophilic Esophagitis Drug Market
9.1.5.3.1 Mexico Eosinophilic Esophagitis Drug Market by Drug Type
9.1.5.3.2 Mexico Eosinophilic Esophagitis Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Eosinophilic Esophagitis Drug Market Overview
9.2.2 Europe Eosinophilic Esophagitis Drug Market Forecasts and Analysis
9.2.3 Europe Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Eosinophilic Esophagitis Drug Market
9.2.5.1.1 Germany Eosinophilic Esophagitis Drug Market by Drug Type
9.2.5.1.2 Germany Eosinophilic Esophagitis Drug Market by Distribution Channel
9.2.5.2 France Eosinophilic Esophagitis Drug Market
9.2.5.2.1 France Eosinophilic Esophagitis Drug Market by Drug Type
9.2.5.2.2 France Eosinophilic Esophagitis Drug Market by Distribution Channel
9.2.5.3 Italy Eosinophilic Esophagitis Drug Market
9.2.5.3.1 Italy Eosinophilic Esophagitis Drug Market by Drug Type
9.2.5.3.2 Italy Eosinophilic Esophagitis Drug Market by Distribution Channel
9.2.5.4 Spain Eosinophilic Esophagitis Drug Market
9.2.5.4.1 Spain Eosinophilic Esophagitis Drug Market by Drug Type
9.2.5.4.2 Spain Eosinophilic Esophagitis Drug Market by Distribution Channel
9.2.5.5 United Kingdom Eosinophilic Esophagitis Drug Market
9.2.5.5.1 United Kingdom Eosinophilic Esophagitis Drug Market by Drug Type
9.2.5.5.2 United Kingdom Eosinophilic Esophagitis Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Overview
9.3.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Eosinophilic Esophagitis Drug Market
9.3.5.1.1 Australia Eosinophilic Esophagitis Drug Market by Drug Type
9.3.5.1.2 Australia Eosinophilic Esophagitis Drug Market by Distribution Channel
9.3.5.2 China Eosinophilic Esophagitis Drug Market
9.3.5.2.1 China Eosinophilic Esophagitis Drug Market by Drug Type
9.3.5.2.2 China Eosinophilic Esophagitis Drug Market by Distribution Channel
9.3.5.3 India Eosinophilic Esophagitis Drug Market
9.3.5.3.1 India Eosinophilic Esophagitis Drug Market by Drug Type
9.3.5.3.2 India Eosinophilic Esophagitis Drug Market by Distribution Channel
9.3.5.4 Japan Eosinophilic Esophagitis Drug Market
9.3.5.4.1 Japan Eosinophilic Esophagitis Drug Market by Drug Type
9.3.5.4.2 Japan Eosinophilic Esophagitis Drug Market by Distribution Channel
9.3.5.5 South Korea Eosinophilic Esophagitis Drug Market
9.3.5.5.1 South Korea Eosinophilic Esophagitis Drug Market by Drug Type
9.3.5.5.2 South Korea Eosinophilic Esophagitis Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Overview
9.4.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Eosinophilic Esophagitis Drug Market
9.4.5.1.1 South Africa Eosinophilic Esophagitis Drug Market by Drug Type
9.4.5.1.2 South Africa Eosinophilic Esophagitis Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Eosinophilic Esophagitis Drug Market
9.4.5.2.1 Saudi Arabia Eosinophilic Esophagitis Drug Market by Drug Type
9.4.5.2.2 Saudi Arabia Eosinophilic Esophagitis Drug Market by Distribution Channel
9.4.5.3 U.A.E Eosinophilic Esophagitis Drug Market
9.4.5.3.1 U.A.E Eosinophilic Esophagitis Drug Market by Drug Type
9.4.5.3.2 U.A.E Eosinophilic Esophagitis Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Eosinophilic Esophagitis Drug Market Overview
9.5.2 South and Central America Eosinophilic Esophagitis Drug Market Forecasts and Analysis
9.5.3 South and Central America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Eosinophilic Esophagitis Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Eosinophilic Esophagitis Drug Market
9.5.5.1.1 Brazil Eosinophilic Esophagitis Drug Market by Drug Type
9.5.5.1.2 Brazil Eosinophilic Esophagitis Drug Market by Distribution Channel
9.5.5.2 Argentina Eosinophilic Esophagitis Drug Market
9.5.5.2.1 Argentina Eosinophilic Esophagitis Drug Market by Drug Type
9.5.5.2.2 Argentina Eosinophilic Esophagitis Drug Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. EOSINOPHILIC ESOPHAGITIS DRUG MARKET, KEY COMPANY PROFILES
11.1. BOSTON SCIENTIFIC CORPORATION
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GSK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ADARE PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. DBV TECHNOLOGIES
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DR. FALK PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. QUORUM INNOVATIONS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TAKEDA PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CALYPSO BIOTECH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CELGENE
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. REGENERON
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Boston Scientific Corporation
2. AstraZeneca
3. GSK
4. Adare Pharmaceuticals
5. DBV Technologies
6. Dr. Falk Pharma
7. Quorum Innovations
8. Takeda Pharmaceuticals
9. Calypso Biotech
10. Celgene
11. Regeneron

TIPRE00008611
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking